Sector News

Wacker Chemie reports biggest-ever loss due to lower polysilicon prices and huge asset writedown

January 28, 2020
Chemical Value Chain

Wacker Chemie today announced its preliminary fourth-quarter and full-year 2019 results, reporting its biggest full-year loss in the company’s history.

In December, Wacker issued a profit warning and announced a major impairment charge against its polysilicon plants because of more pessimistic expectations for future earnings prospects in solar-grade polysilicon. Fourth-quarter EBITDA was down 10% to €155 million ($170.8 million) on sales 2.4% lower at €1.16 billion.

For full-year 2019, Wacker reported a net loss of €630 million compared with a net profit of €260 million in 2018. Reported EBITDA declined 16% to €780 million but was flattered by a €112.5 million insurance payment in the third quarter for the damage incurred at its Charleston, Tennessee, polysilicon plant in 2017. Excluding this one-off effect, EBITDA dropped 28% to €667.5 million. Reported EBIT collapsed from €390 million in 2018 to a loss of €540 million last year, largely due to the one time impairment charge of €760 million against the company’s polysilicon assets. Excluding this charge and the insurance gain, like-on-like EBIT fell from €390 million to €117.5 million.

Earnings were hit not only by markedly reduced prices for solar-grade polysilicon and by associated inventory valuation adjustments, but also by lower prices for standard silicone and by the steep rise in German electricity prices. Wacker Polysilicon’s EBITDA fell from €72 million in 2018 to an EBITDA loss, excluding the insurance payment, of €57.5 million, while Wacker Silicones reported EBITDA down 22% on the year before to €480 million. On a positive note, EBITDA at Wacker Polymers and Wacker Biosolutions rose 32% and 25% year-on-year to €195 million and €30 million, respectively.

Sales in 2019 fell 1% compared with the year before to €4.93 billion, mainly due to lower prices for solar-grade polysilicon but also for standard silicones. Sales were supported by higher volumes overall, by product-mix effects, and by the year-over-year rise in the US dollar.

“Our earnings last year were strongly influenced by non-recurring effects from insurance compensation received and from the impairment charge on fixed assets,” said Rudolf Staudigl, CEO. “In operating terms, especially our chemical business continued to perform well. After an exceptionally strong 2018, silicone margins resumed normal levels, while we achieved substantial profitability gains in dispersions, dispersible polymer powders and bioengineered products. Underlying conditions, however, remained unsatisfactory for solar-grade polysilicon, where prices fell markedly last year amid high overcapacity built up by state-subsidized competitors in China.

Staudigl added, “We are currently working on a comprehensive program to make Wacker more efficient and capable, and to achieve substantial cost savings. We expect already to announce concrete targets for this initiative in Q1 2020.”

By Natasha Alperowicz

Source: Chemical Week

Join the discussion!

Your email address will not be published. Required fields are marked *

Related News

January 23, 2021

Supervisory Board of Bayer AG appoints Sarena Lin to Board of Management as Chief Transformation and Talent Officer

Chemical Value Chain

Lin will become the company’s Chief Transformation and Talent Officer. She will be responsible for Human Resources, Strategy and Business Consulting and drive the accelerated transformation of Bayer.

January 23, 2021

Johnson Matthey’s battery plant in Poland to be powered by renewable electricity 

Chemical Value Chain

Johnson Matthey plc (JM; London) has confirmed that its battery cathode materials plant in Konin, Poland, will be powered solely by electricity from renewable sources from day one of production.

January 23, 2021

Oxford given £100m for antibiotic resistance research

Chemical Value Chain

Britain’s Oxford University has received a donation of £100 million (112 million euros, $136 million) to research growing resistance to antibiotics, the university announced on Tuesday. The sum, from British chemicals multinational Ineos, is one of the largest donations given to Oxford University in its long history.

Send this to a friend